An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir.
An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir.
Intern Med. 2019 Sep 18;:
Authors: Hosoda T, Uehara Y, Naito T
Abstract
Patients with HIV infection represent a high-risk group for medication overdose because of the high frequency of complicating psychiatric disorders. Raltegravir is well-known for its low frequency of adverse effects. We herein report a 42-year-old Japanese man with HIV infection who was hospitalized 6 hours after overdosing with 24,000 mg of raltegravir in a suicide attempt. No serious adverse events occurred, although the plasma concentration of raltegravir at 18 hours after the overdose was 79,871.1 ng/mL. Raltegravir may be well-indicated for HIV patients at risk of overdosing.
PMID: 31534087 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
More News: Depression | Internal Medicine | Isentress | Japan Health | Overdose | Psychiatry | Suicide